These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 29080209)

  • 1. Association between Serum Amiodarone and N-Desethylamiodarone Concentrations and Development of Thyroid Dysfunction.
    Yamato M; Wada K; Hayashi T; Fujimoto M; Hosomi K; Oita A; Takada M
    Clin Drug Investig; 2018 Jan; 38(1):39-48. PubMed ID: 29080209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between N-desethylamiodarone/amiodarone ratio and amiodarone-induced thyroid dysfunction.
    Yamato M; Wada K; Fujimoto M; Hosomi K; Hayashi T; Oita A; Takada M
    Eur J Clin Pharmacol; 2017 Mar; 73(3):289-296. PubMed ID: 28083650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amiodarone-induced thyroid dysfunction in an iodine-replete area: epidemiological and clinical data.
    Zosin I; Balaş M
    Endokrynol Pol; 2012; 63(1):2-9. PubMed ID: 22378090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic particularities in amiodarone induced thyroid disorder in patients with underlying cardiac condition.
    Costache L; Mogos V; Preda C; Vulpoi C; Ungureanu MC
    Rev Med Chir Soc Med Nat Iasi; 2014; 118(4):959-64. PubMed ID: 25581954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amiodarone-induced thyroid dysfunction in cardiac patients from areas with iodine deficiency.
    Trifănescu R; Fica S; Barbu C; Vârtej I; Ursu H; Bunghez R; Coculescu M
    Rom J Intern Med; 2004; 42(3):595-605. PubMed ID: 16366133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The effects of amiodarone on the thyroid].
    Toni M; Anda E; Pineda J; Martínez de Esteban JP; Ollero MD
    An Sist Sanit Navar; 2009; 32(3):363-70. PubMed ID: 20094097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Amiodarone and thyroid disorders--prospective study and review of the literature].
    Vandergheynst F; Liénart F; Ducobu J
    Rev Med Brux; 1999 Oct; 20(5):411-7. PubMed ID: 10582476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucocorticoid response in amiodarone-induced thyrotoxicosis resulting from destructive thyroiditis is predicted by thyroid volume and serum free thyroid hormone concentrations.
    Bogazzi F; Bartalena L; Tomisti L; Rossi G; Tanda ML; Dell'Unto E; Aghini-Lombardi F; Martino E
    J Clin Endocrinol Metab; 2007 Feb; 92(2):556-62. PubMed ID: 17148557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amiodarone-induced thyroid dysfunction in the Hong Kong Chinese population.
    Lee KF; Lee KM; Fung TT
    Hong Kong Med J; 2010 Dec; 16(6):434-9. PubMed ID: 21135419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical characteristics of amiodarone-induced thyrotoxicosis and hypothyroidism in Japan.
    Sato K; Miyakawa M; Eto M; Inaba T; Matsuda N; Shiga T; Ohnishi S; Kasanuki H
    Endocr J; 1999 Jun; 46(3):443-51. PubMed ID: 10503998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence and predictability of amiodarone-induced thyrotoxicosis and hypothyroidism.
    Hofmann A; Nawara C; Ofluoglu S; Holzmannhofer J; Strohmer B; Pirich C
    Wien Klin Wochenschr; 2008; 120(15-16):493-8. PubMed ID: 18820854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The clinical value of regular thyroid function tests during amiodarone treatment.
    Benjamens S; Dullaart RPF; Sluiter WJ; Rienstra M; van Gelder IC; Links TP
    Eur J Endocrinol; 2017 Jul; 177(1):9-14. PubMed ID: 28424174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determinants and outcome of amiodarone-associated thyroid dysfunction.
    Ahmed S; Van Gelder IC; Wiesfeld AC; Van Veldhuisen DJ; Links TP
    Clin Endocrinol (Oxf); 2011 Sep; 75(3):388-94. PubMed ID: 21535072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subclinical hypothyroidism, overt thyrotoxicosis and subclinical hypothyroidism: the subsequent phases of thyroid function in a patient chronically treated with amiodarone.
    Minelli R; Gardini E; Bianconi L; Salvi M; Roti E
    J Endocrinol Invest; 1992 Dec; 15(11):853-5. PubMed ID: 1291598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Every sixth patient in amiodarone treatment develops thyrotoxicosis or hypothyreosis].
    Olsen JS; Carlé A; Thomsen HH
    Ugeskr Laeger; 2014; 176(34):. PubMed ID: 25293567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cardiovascular manifestations of thyrotoxicosis and thyroid dysfunction caused by amiodarone].
    Simkó J; Barta K; Szabó Z; Varga E; Nagy E; Lorincz I
    Orv Hetil; 2004 Nov; 145(48):2411-7. PubMed ID: 15638034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Incidence and predictors of thyroid dysfunction caused by long-term intake of amiodaron].
    Serdiuk SE; Bakalov SA; Golitsyn SP; Molashenko NV; Platonova NM; Sviridenko NIu
    Ter Arkh; 2005; 77(10):33-9. PubMed ID: 16320682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amiodarone induced thyroid dysfunction: pathophysiology, diagnosis and management.
    Sandhu RS; Davies PH
    Adverse Drug React Toxicol Rev; 2001 Jun; 20(2):105-16. PubMed ID: 11481999
    [No Abstract]   [Full Text] [Related]  

  • 19. Amiodarone-induced thyroid dysfunction.
    Danzi S; Klein I
    J Intensive Care Med; 2015 May; 30(4):179-85. PubMed ID: 24067547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amiodarone-induced thyroid dysfunction in Taiwan: a retrospective cohort study.
    Huang CJ; Chen PJ; Chang JW; Huang DF; Chang SL; Chen SA; Jap TS; Lin LY
    Int J Clin Pharm; 2014 Apr; 36(2):405-11. PubMed ID: 24515549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.